Main Management ETF Advisors »

Crispr Therapeutics shares owned by Main Management ETF Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Main Management ETF Advisors from 13F filings

Historical chart of Main Management ETF Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Main Management ETF Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Main Management ETF Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 18k 64.80
2025-06-30 $963k 20k 48.66
2025-03-31 $662k 20k 34.01
2024-12-31 $532k 14k 39.33
2024-09-30 $693k 15k 47.00

More positions owned by Main Management ETF Advisors

Technology SPDR (XLK)
Select Sector Spdr Tr Communic etfeqty (XLC)
Health Care SPDR (XLV)
Financial Select Sector SPDR (XLF)
Consumer Discretionary SPDR (XLY)
Vaneck Vectors Semiconductor Etf semiconductor (SMH)
iShares S&P NA Tec.-SW. Idx. Fund (IGV)
iShares Dow Jones US Home Const. (ITB)
Ishares Tr core msci intl (IDEV)
Ishares Inc core msci emkt (IEMG)
State Street Institutional Treasury MM Fund (TRIXX)
Spdr Index Shs Fds stoxx eur 50 etf (SPEU)
Kraneshares Tr csi chi internet (KWEB)
SPDR S&P Emerging Markets (SPEM)
Network Associates Inc cl a (NET)

View all positions for Main Management ETF Advisors

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics